Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Reaching beyond 80% BSN-prepared nurses: One organization's journey to success.

Straka KL, Hupp DS, Ambrose HL, Christy L.

Nurs Manage. 2019 May;50(5):52-54. doi: 10.1097/01.NUMA.0000557624.27437.25. No abstract available.

PMID:
31045713
2.

A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA-Mutated Breast and Gynecologic Cancers.

Banerji U, Dean EJ, Pérez-Fidalgo JA, Batist G, Bedard PL, You B, Westin SN, Kabos P, Garrett MD, Tall M, Ambrose H, Barrett JC, Carr TH, Cheung SYA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Elvin P, Foxley A, Lawrence P, Lindemann JPO, Maudsley R, Pass M, Rowlands V, Rugman P, Schiavon G, Yates J, Schellens JHM.

Clin Cancer Res. 2018 May 1;24(9):2050-2059. doi: 10.1158/1078-0432.CCR-17-2260. Epub 2017 Oct 24.

3.

AKT Inhibition in Solid Tumors With AKT1 Mutations.

Hyman DM, Smyth LM, Donoghue MTA, Westin SN, Bedard PL, Dean EJ, Bando H, El-Khoueiry AB, Pérez-Fidalgo JA, Mita A, Schellens JHM, Chang MT, Reichel JB, Bouvier N, Selcuklu SD, Soumerai TE, Torrisi J, Erinjeri JP, Ambrose H, Barrett JC, Dougherty B, Foxley A, Lindemann JPO, McEwen R, Pass M, Schiavon G, Berger MF, Chandarlapaty S, Solit DB, Banerji U, Baselga J, Taylor BS.

J Clin Oncol. 2017 Jul 10;35(20):2251-2259. doi: 10.1200/JCO.2017.73.0143. Epub 2017 May 10. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):360.

4.

Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients.

de Bruin EC, Whiteley JL, Corcoran C, Kirk PM, Fox JC, Armisen J, Lindemann JPO, Schiavon G, Ambrose HJ, Kohlmann A.

PLoS One. 2017 May 4;12(5):e0175779. doi: 10.1371/journal.pone.0175779. eCollection 2017.

5.

Systematic Review of Surgical Literature from Resource-Limited Countries: Developing Strategies for Success.

Pauyo T, Debas HT, Kyamanywa P, Kushner AL, Jani PG, Lavy C, Dakermandji M, Ambrose H, Khwaja K, Razek T, Deckelbaum DL.

World J Surg. 2015 Sep;39(9):2173-81. doi: 10.1007/s00268-015-3102-9. Review.

PMID:
26037025
6.

Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?

Birmingham BK, Bujac SR, Elsby R, Azumaya CT, Wei C, Chen Y, Mosqueda-Garcia R, Ambrose HJ.

Eur J Clin Pharmacol. 2015 Mar;71(3):341-55. doi: 10.1007/s00228-014-1801-z. Epub 2015 Feb 12.

PMID:
25673568
7.

Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.

Birmingham BK, Bujac SR, Elsby R, Azumaya CT, Zalikowski J, Chen Y, Kim K, Ambrose HJ.

Eur J Clin Pharmacol. 2015 Mar;71(3):329-40. doi: 10.1007/s00228-014-1800-0. Epub 2015 Jan 30.

PMID:
25630984
8.

Bedside management considerations in the treatment of pit viper envenomation.

Smith S, Sammons SS, Carr J, King TR, Ambrose HS, Zimmet L, Repasky TM.

J Emerg Nurs. 2014 Nov;40(6):537-45. doi: 10.1016/j.jen.2014.01.002. Epub 2014 Mar 31. Review. No abstract available.

PMID:
24698390
9.

The impact and perception of nursing certification in pediatric nursing.

Straka KL, Ambrose HL, Burkett M, Capan M, Flook D, Evangelista T, Houck P, Lukanski A, Schenkel K, Thornton M.

J Pediatr Nurs. 2014 May-Jun;29(3):205-11. doi: 10.1016/j.pedn.2013.10.010. Epub 2013 Oct 31.

PMID:
24263250
10.

Nursing portfolio study: the use in annual performance reviews.

Capan ML, Ambrose HL, Burkett M, Evangelista TR, Flook DM, Straka KL.

J Nurses Prof Dev. 2013 Jul-Aug;29(4):182-5. doi: 10.1097/NND.0b013e31829aec0f.

PMID:
23877288
11.

Effect of β2-adrenergic receptor gene (ADRB2) 3' untranslated region polymorphisms on inhaled corticosteroid/long-acting β2-adrenergic agonist response.

Ambrose HJ, Lawrance RM, Cresswell CJ, Goldman M, Meyers DA, Bleecker ER.

Respir Res. 2012 May 4;13:37. doi: 10.1186/1465-9921-13-37.

12.

Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England.

Ambrose HE, Granerod J, Clewley JP, Davies NW, Keir G, Cunningham R, Zuckerman M, Mutton KJ, Ward KN, Ijaz S, Crowcroft NS, Brown DW; UK Aetiology of Encephalitis Study Group.

J Clin Microbiol. 2011 Oct;49(10):3576-83. doi: 10.1128/JCM.00862-11. Epub 2011 Aug 24.

13.

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.

Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group.

Lancet Infect Dis. 2010 Dec;10(12):835-44. doi: 10.1016/S1473-3099(10)70222-X. Epub 2010 Oct 15. Erratum in: Lancet Infect Dis. 2011 Feb;11(2):79.

14.

Causality in acute encephalitis: defining aetiologies.

Granerod J, Cunningham R, Zuckerman M, Mutton K, Davies NW, Walsh AL, Ward KN, Hilton DA, Ambrose HE, Clewley JP, Morgan D, Lunn MP, Solomon T, Brown DW, Crowcroft NS.

Epidemiol Infect. 2010 Jun;138(6):783-800. doi: 10.1017/S0950268810000725. Epub 2010 Apr 14. Review.

PMID:
20388231
15.

Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey.

Clewley JP, Kelly CM, Andrews N, Vogliqi K, Mallinson G, Kaisar M, Hilton DA, Ironside JW, Edwards P, McCardle LM, Ritchie DL, Dabaghian R, Ambrose HE, Gill ON.

BMJ. 2009 May 21;338:b1442. doi: 10.1136/bmj.b1442.

16.

Poly(ADP-ribose) polymerase-1 (Parp-1)-deficient mice demonstrate abnormal antibody responses.

Ambrose HE, Willimott S, Beswick RW, Dantzer F, de Murcia JM, Yelamos J, Wagner SD.

Immunology. 2009 Jun;127(2):178-86. doi: 10.1111/j.1365-2567.2008.02921.x. Epub 2008 Sep 4.

17.

Analysis of the surveillance situation for viral encephalitis and meningitis in Europe.

Donoso Mantke O, Vaheri A, Ambrose H, Koopmans M, de Ory F, Zeller H, Beyrer K, Windorfer A, Niedrig M; European Network for Diagnostics of Imported Viral Diseases (ENIVD) Working Group for Viral CNS Diseases.

Euro Surveill. 2008 Jan 17;13(3). pii: 8017. Review.

18.

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.

Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M.

Lancet. 2007 Dec 22;370(9605):2118-25. Review.

PMID:
18156033
19.

Percutaneous pins versus volar plates for unstable distal radius fractures: a biomechanic study using a cadaver model.

Knox J, Ambrose H, McCallister W, Trumble T.

J Hand Surg Am. 2007 Jul-Aug;32(6):813-7.

PMID:
17606059
20.

Poly-(ADP-ribose) polymerase-1 (Parp-1) binds in a sequence-specific manner at the Bcl-6 locus and contributes to the regulation of Bcl-6 transcription.

Ambrose HE, Papadopoulou V, Beswick RW, Wagner SD.

Oncogene. 2007 Sep 13;26(42):6244-52. Epub 2007 Apr 2.

PMID:
17404575
21.

Virus discovery by sequence-independent genome amplification.

Ambrose HE, Clewley JP.

Rev Med Virol. 2006 Nov-Dec;16(6):365-83. Review.

PMID:
16929467
22.

Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region.

Wang Z, Sew PH, Ambrose H, Ryan S, Chong SS, Lee EJ, Lee CG.

BMC Genomics. 2006 May 10;7:111.

23.

Comparison of pullout button versus suture anchor for zone I flexor tendon repair.

McCallister WV, Ambrose HC, Katolik LI, Trumble TE.

J Hand Surg Am. 2006 Feb;31(2):246-51.

PMID:
16473686
24.

Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.

Lee E, Ryan S, Birmingham B, Zalikowski J, March R, Ambrose H, Moore R, Lee C, Chen Y, Schneck D.

Clin Pharmacol Ther. 2005 Oct;78(4):330-41.

PMID:
16198652
26.

Genotypic variation in Pneumocystis jirovecii isolates in Britain.

Miller RF, Lindley AR, Copas A, Ambrose HE, Davies RJ, Wakefield AE.

Thorax. 2005 Aug;60(8):679-82.

27.

Isolates of Pneumocystis jirovecii from Harare show high genotypic similarity to isolates from London at the superoxide dismutase locus.

Miller RF, Lindley AR, Malin AS, Ambrose HE, Wakefield AE.

Trans R Soc Trop Med Hyg. 2005 Mar;99(3):202-6.

PMID:
15653122
28.

Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.

Carr ME Jr, Martin EJ, Kuhn JG, Ambrose H, Fern S, Bryant PC.

Clin Lab. 2004;50(9-10):529-38.

PMID:
15481628
29.
30.

Expression and complexity of the PRT1 multigene family of Pneumocystis carinii.

Ambrose HE, Keely SP, Aliouat EM, Dei-Cas E, Wakefield AE, Miller RF, Stringer JR.

Microbiology. 2004 Feb;150(Pt 2):293-300. doi: 10.1099/mic.0.26539-0.

PMID:
14766907
31.

Multilocus genotyping of Pneumocystis jirovecii from adult HIV-infected patients with Pneumocystis pneumonia.

Miller RF, Lindley AR, Ambrose HE, Aliouat-Denis CM, Wakefield AE.

J Eukaryot Microbiol. 2003;50 Suppl:654-5. No abstract available.

PMID:
14736205
32.

Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.

Miller RF, Lindley AR, Ambrose HE, Malin AS, Wakefield AE.

Antimicrob Agents Chemother. 2003 Dec;47(12):3979-81.

33.

Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients.

Wakefield AE, Lindley AR, Ambrose HE, Denis CM, Miller RF.

J Infect Dis. 2003 Mar 15;187(6):901-8. Epub 2003 Mar 6.

PMID:
12660936
34.

SNPs and pharmacogenomics.

Ambrose HJ.

Pharmacogenomics. 2002 Sep;3(5):583-6. No abstract available.

PMID:
12223045
35.

Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis infection.

Miller RF, Ambrose HE, Novelli V, Wakefield AE.

J Clin Microbiol. 2002 Apr;40(4):1555-7.

36.
37.

Distribution of Pneumocystis carinii f. sp. hominis types in the lung of a child dying of Pneumocystis pneumonia.

Ambrose HE, Ponce CA, Wakefield AE, Miller RF, Vargas SL.

Clin Infect Dis. 2001 Nov 1;33(9):e100-2. Epub 2001 Sep 24.

PMID:
11568852
38.

Arthroscopic localization of medial collateral ligament injury: Report of 2 cases in adults.

Ambrose HC, Simonian PT, Sims WF.

Arthroscopy. 2001 May;17(5):E21.

PMID:
11337708
39.

Molecular characterization of a new alpha-1-antitrypsin M variant allele, Mwhitstable: implications for DNA-based diagnosis.

Ambrose HJ, Chambers SM, Mieli-Vergani G, Ferrie R, Newton CR, Robertson NH.

Diagn Mol Pathol. 1999 Dec;8(4):205-10.

PMID:
10617277
40.

Tissue-selective expression of alpha-dystrobrevin is determined by multiple promoters.

Holzfeind PJ, Ambrose HJ, Newey SE, Nawrotzki RA, Blake DJ, Davies KE.

J Biol Chem. 1999 Mar 5;274(10):6250-8.

41.

Genomic organization and refined mapping of the mouse beta-dystrobrevin gene.

Loh NY, Ambrose HJ, Guay-Woodford LM, DasGupta S, Nawrotzki RA, Blake DJ, Davies KE.

Mamm Genome. 1998 Nov;9(11):857-62.

PMID:
9799833
42.

Construction of a transcription map around the gene for ataxia telangiectasia: identification of at least four novel genes.

Stankovic T, Byrd PJ, Cooper PR, McConville CM, Munroe DJ, Riley JH, Watts GD, Ambrose H, McGuire G, Smith AD, Sutcliffe A, Mills T, Taylor AM.

Genomics. 1997 Mar 1;40(2):267-76.

PMID:
9119394
43.

Genomic organization of the mouse dystrobrevin gene: comparative analysis with the dystrophin gene.

Ambrose HJ, Blake DJ, Nawrotzki RA, Davies KE.

Genomics. 1997 Feb 1;39(3):359-69.

PMID:
9119373
44.

A member of the MAP kinase phosphatase gene family in mouse containing a complex trinucleotide repeat in the coding region.

Theodosiou AM, Rodrigues NR, Nesbit MA, Ambrose HJ, Paterson H, McLellan-Arnold E, Boyd Y, Leversha MA, Owen N, Blake DJ, Ashworth A, Davies KE.

Hum Mol Genet. 1996 May;5(5):675-84.

PMID:
8733137
45.

A novel gene, DXS8237E, lies within 20 kb upstream of UBE1 in Xp11.23 and has a different X inactivation status.

Coleman MP, Ambrose HJ, Carrel L, Németh AH, Willard HF, Davies KE.

Genomics. 1996 Jan 1;31(1):135-8.

PMID:
8808293
46.

Genetic and physical mapping of the ataxia-telangiectasia locus on chromosome 11q22-q23.

McConville CM, Byrd PJ, Ambrose HJ, Taylor AM.

Int J Radiat Biol. 1994 Dec;66(6 Suppl):S45-56. Review.

PMID:
7836852
47.

A physical map across chromosome 11q22-q23 containing the major locus for ataxia telangiectasia.

Ambrose HJ, Byrd PJ, McConville CM, Cooper PR, Stankovic T, Riley JH, Shiloh Y, McNamara JO, Fukao T, Taylor AM.

Genomics. 1994 Jun;21(3):612-9.

PMID:
7959739
48.

Paired STSs amplified from radiation hybrids, and from associated YACs, identify highly polymorphic loci flanking the ataxia telangiectasia locus on chromosome 11q22-23.

McConville CM, Byrd PJ, Ambrose HJ, Stankovic T, Ziv Y, Bar-Shira A, Vanagaite L, Rotman G, Shiloh Y, Gillett GT, et al.

Hum Mol Genet. 1993 Jul;2(7):969-74.

PMID:
8364579
49.

The order and orientation of a cluster of metalloproteinase genes, stromelysin 2, collagenase, and stromelysin, together with D11S385, on chromosome 11q22-q23.

Formstone CJ, Byrd PJ, Ambrose HJ, Riley JH, Hernandez D, McConville CM, Taylor AM.

Genomics. 1993 Apr;16(1):289-91.

PMID:
8486377

Supplemental Content

Loading ...
Support Center